tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MLYS Stock Latest News

Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch
Company AnnouncementsMineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch
2d ago
MLYS
Mineralys Therapeutics: Lorundrostat’s Broad Efficacy, Favorable Safety, and Upside Indications Support Buy Rating on MLYS
PremiumRatings
Mineralys Therapeutics: Lorundrostat’s Broad Efficacy, Favorable Safety, and Upside Indications Support Buy Rating on MLYS
9d ago
MLYS
Mineralys updates lorundrostat program and upcoming data milestones
PremiumCompany Announcements
Mineralys updates lorundrostat program and upcoming data milestones
9d ago
8K
MLYS
Mineralys Therapeutics provides corporate update
PremiumThe Fly
Mineralys Therapeutics provides corporate update
9d ago
MLYS
Mineralys Therapeutics price target raised to $46 from $43 at BofA
PremiumThe Fly
Mineralys Therapeutics price target raised to $46 from $43 at BofA
27d ago
MLYS
Mineralys Therapeutics price target raised to $52 from $45 at Stifel
PremiumThe FlyMineralys Therapeutics price target raised to $52 from $45 at Stifel
27d ago
MLYS
Mineralys Therapeutics falls -11.3%
Premium
The Fly
Mineralys Therapeutics falls -11.3%
2M ago
MLYS
Mineralys Therapeutics falls -13.9%
Premium
The Fly
Mineralys Therapeutics falls -13.9%
2M ago
MLYS
Mineralys Therapeutics price target raised to $56 from $52 at H.C. Wainwright
PremiumThe Fly
Mineralys Therapeutics price target raised to $56 from $52 at H.C. Wainwright
2M ago
MLYS
Mineralys Therapeutics’ Earnings Call Highlights Positive Outlook
PremiumCompany Announcements
Mineralys Therapeutics’ Earnings Call Highlights Positive Outlook
2M ago
MLYS
Mineralys Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Mineralys Therapeutics Reports Q3 2025 Financial Results
2M ago
MLYS
Mineralys Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Mineralys Therapeutics files automatic mixed securities shelf
2M ago
MLYS
Mineralys Therapeutics reports Q3 EPS (52c), consensus (61c)
PremiumThe FlyMineralys Therapeutics reports Q3 EPS (52c), consensus (61c)
2M ago
MLYS
Unusually active option classes on open November 10th
Premium
The Fly
Unusually active option classes on open November 10th
2M ago
B
AG
Mineralys Therapeutics, Inc. (MLYS) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Mineralys Therapeutics, Inc. (MLYS) Q3 Earnings Cheat Sheet
2M ago
MLYS
Mineralys Therapeutics price target raised to $52 from $42 at H.C. Wainwright
PremiumThe Fly
Mineralys Therapeutics price target raised to $52 from $42 at H.C. Wainwright
3M ago
MLYS
Mineralys Therapeutics completes enrollment in Phase 2 EXPLORE-OSA trial
PremiumThe Fly
Mineralys Therapeutics completes enrollment in Phase 2 EXPLORE-OSA trial
4M ago
MLYS
Insiders Pour Millions into These 2 Stocks — Goldman Sachs Backs the Move
PremiumStock Analysis & Ideas
Insiders Pour Millions into These 2 Stocks — Goldman Sachs Backs the Move
4M ago
SFD
MLYS
Mineralys Therapeutics falls -4.9%
PremiumThe Fly
Mineralys Therapeutics falls -4.9%
4M ago
MLYS
Mineralys Therapeutics price target raised to $50 from $26 at Wells Fargo
PremiumThe FlyMineralys Therapeutics price target raised to $50 from $26 at Wells Fargo
4M ago
MLYS
Buy Rating for Mineralys Therapeutics, Inc. Driven by Promising Phase 3 Results and Strong Financial Position
Premium
Ratings
Buy Rating for Mineralys Therapeutics, Inc. Driven by Promising Phase 3 Results and Strong Financial Position
4M ago
MLYS
Buy Rating Affirmed for Mineralys Therapeutics Due to Promising Hypertension Drug Data and Market Position
Premium
Ratings
Buy Rating Affirmed for Mineralys Therapeutics Due to Promising Hypertension Drug Data and Market Position
4M ago
MLYS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >